USE OF BISMUTH DRUGS IN THERAPY OF GASTROENTEROLOGIC PATIENTS AND IN ERADICATION SCHEMES TAKING INTO ACCOUNT MAASTRICHT V RECOMMENDATIONS

Abstract

The article provides Maastricht V recommendations on management of ulcer disease patients. Possibilities of use of bismuth preparations in new recommendations in therapy of pathologies of upper departments of the gastrointestinal tract are considered. Materials of Russian studies on Novobismol drug in therapy of chronic gastritis, ulcer disease are provided by results of which the drug is characterized as effective.

Keywords

• chronic gastrictis
• ulcer gastric disease
• helicobacter pylori-гастрит
• maastricht v
• bismuth tricalcium dicitrate
• novobismol